Management of Dyslipidemia in Secondary Prevention of Cardiovascular Disease: The Gap between Theory and Practice

J Clin Med. 2022 Aug 8;11(15):4608. doi: 10.3390/jcm11154608.

Abstract

Hypercholesterolemia is one of the most important modifiable risk factors for cardiovascular events (CV) representing the principal driving force in the development of atherosclerotic cardiovascular diseases (ASCVD) [...].

Publication types

  • Editorial

Grants and funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.